Jim Simons’s Procept Biorobotics PRCT Stock Holding History

Jim Simons’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-116,166	Closed	-$2.91M	–	3539
2026 Q1	$2.91M	Sell	116,166 -1,300	-1%	-$36.6K	﹤0.01%	1680
2025 Q4	$3.7M	Buy	+117,466	New	+$3.9M	0.01%	1502
2025 Q2	–	Sell	-314,466	Closed	-$18.3M	–	3818
2025 Q1	$18.3M	Buy	314,466 +36,000	+13%	+$2.46M	0.03%	700
2024 Q4	$22.4M	Buy	+278,466	New	+$23.8M	0.03%	614
2024 Q3	–	Sell	-45,966	Closed	-$2.81M	–	3806
2024 Q2	$2.81M	Buy	+45,966	New	+$2.73M	﹤0.01%	1660
2023 Q2	–	Sell	-63,566	Closed	-$1.8M	–	4196
2023 Q1	$1.8M	Buy	+63,566	New	+$2.24M	﹤0.01%	2090
2022 Q1	–	Sell	-179,300	Closed	-$4.48M	–	4375
2021 Q4	$4.48M	Buy	+179,300	New	+$6.63M	0.01%	1602

Other funds holding PRCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $100B AUM 45.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jim Simons's PRCT Position: Q2 2026 in Review

Jim Simons sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 116,166 shares — an estimated $2.91M sold.

Jim Simons first reported a position in PRCT in Q4 2021 and held it in 7 quarters. The position peaked at $22.4M in Q4 2024. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

Jim Simons reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
Jim Simons sold 116,166 Procept Biorobotics shares in Q2 2026, an estimated $2.91M.
Jim Simons first reported a position in Procept Biorobotics in Q4 2021 and held it in 7 quarters.
Jim Simons's Procept Biorobotics position peaked at $22.4M in Q4 2024.
253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.